Mouse MCP-1(Monocyte Chemotactic Protein 1) ELISA Kit
中文名称:小鼠单核细胞趋化蛋白1(MCP-1)酶联免疫吸附测定试剂盒
别称:
CCL2、GDCF-2、HC11、HSMCR30、MCAF、MCP1、SCYA2、SMC-CF
Price:
Size:
96T
48T
96T*5
- 反应性: Mouse
- 检测范围: 31.25-2000 pg/mL
- 灵敏度: 18.75 pg/mL
产品应用 | ELISA |
检测原理 | 本试剂盒采用双抗体夹心ELISA法。用抗小鼠MCP-1抗体包被于酶标板上,实验时样品(或标准品)中的小鼠MCP-1会与包被抗体结合。后依次加入生物素化的抗小鼠MCP-1抗体和辣根过氧化物酶标记的亲和素,抗小鼠MCP-1抗体与结合在包被抗体上的小鼠MCP-1结合,生物素与亲和素特异性结合而形成免疫复合物,游离的成分被洗去。加入显色底物(TMB),TMB在辣根过氧化物酶的催化下呈现蓝色,加终止液后变成黄色。用酶标仪在450 nm波长处测OD值,MCP-1浓度与OD450值之间呈正比,通过绘制标准曲线计算出样品中MCP-1的浓度。 |
反应类型 | Sandwich-ELISA |
规格 |
96T
/ 48T
/ 96T*5
|
反应时间 | 3.5h |
反应性 | Mouse |
检测方法 | Colormetric |
检测范围 | 31.25-2000 pg/mL |
灵敏度 | 18.75 pg/mL |
样本体积 | 100μL |
样本类型 | 血清,血浆,细胞上清,细胞提取液体,组织匀浆等其他生物体液 |
特异性 | 可检测样本中的小鼠MCP-1,且与其它类似物无明显交叉反应 |
精密度 | 板内,板间变异系数均<10% |
回收率 | 80%-120% |
储存条件 | 2-8℃/-20℃ |
数据处理 |
-
The Microglial membrane receptor TREM2 mediates exosome secretion to promote phagocytosis of amyloid-β by microglia
IF: 4.124 -
Limonin ameliorates acute pancreatitis by suppressing JAK2/STAT3 signaling pathway
IF: 4.119 -
Mesenchymal Stem Cells Attenuate Acute Lung Injury in Mice Partly by Suppressing Alveolar Macrophage Activation in a PGE2-Dependent Manner
IF: 4.092 -
Inhibition of LOX-1 prevents inflammation and photoreceptor cell death in retinal degeneration
IF: 3.943 -
IL-17 upregulates MCP-1 expression via Act1 / TRAF6 / TAK1 in experimental autoimmune myocarditis
IF: 3.861 -
IGF2 inhibits hippocampal over-activated microglia and alleviates depression-like behavior in LPS- treated male mice
IF: 3.715Journal:BRAIN RESEARCH BULLETIN -
Effect of Intratracheal Instillation of ZnO Nanoparticles on Acute Lung Inflammation Induced by Lipopolysaccharides in Mice
IF: 3.703Journal:TOXICOLOGICAL SCIENCES -
NLRP3 inflammasome up-regulates major histocompatibility complex class I expression and promotes inflammatory infiltration in polymyositis
IF: 3.594 -
Dendritic cells enhance UHMWPE wear particle‐induced osteoclast differentiation of macrophages
IF: 3.369Journal:JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A -
The protective effects of Pimavanserin against cerebral ischemia-induced brain injury
IF: 3.269